Stock RSPI RESPIRERX PHARMACEUTICALS INC.
Add to a list
To use this feature you must be a member
Log inSign up

News Chart RespireRx Pharmaceuticals Inc.

Equities

RSPI

US7612273059

Delayed OTC Markets
Other stock markets
 18:07:25 31/05/2024 BST 		5-day change 1st Jan Change
0.0031 USD -7.46% Intraday chart for RespireRx Pharmaceuticals Inc. +342.86% +244.44%
04-10 RespireRx Pharmaceuticals Inc. announced that it has received $0.1 million in funding CI
03-20 RespireRx Pharmaceuticals Inc. Reports Publication of Preclinical Research Results Demonstrating the Ability of CX1739, its Lead Clinical AMPAkine, to Improve Bladder Function After Spinal Cord Injury CI
567e3ff73cc8a9682defde222529e.XFeshhBSuOkC1dy2N1BZ-J9TcBOOxYv6IWYfoOcsQfU.H2bm4Eg54KZWtPHzYyppzvQYOVDCnLOQaS9Jx59FKJAQPZjDKDTUuEqC7A~25feb6f3ef44150b52450a406bc96747
  1. Stock Market
  2. Equities
  3. RSPI Stock
  4. Charts RespireRx Pharmaceuticals Inc.
  5. News Chart